The decline in gastric cancer mortality is a major achievement in cancer control. It has been attributed to a set of factors related to the improvement of the populations' living conditions, namely the increase in the consumption of fruit and vegetables and the decrease in salt intake, and therefore labelled as an 'unplanned triumph'. In the last decades, however, we witnessed the gradual acceptance of Helicobacter pylori infection as the most important environmental factor contributing to the occurrence of gastric cancer. The potential for further reducing the burden of cancer by acting on a single modifiable exposure, that is, preventing or treating infection, and the extent to which it may be achieved, requires an in-depth knowledge of the contribution of H. pylori infection to the causal mechanisms leading to cancer. We propose a conceptual framework for the interpretation of the role of H. pylori infection in the web of gastric cancer causation, taking into account the nosological heterogeneity of gastric cancer, the induction period for the action of H. pylori infection and its potential role as a necessary component cause.
Introduction
A continued decline in gastric cancer incidence and mortality has been observed internationally for several decades (Bertuccio et al., 2009 ). The trends, however, are unequal across distinct histological and topographical types. Although the decrease was mainly attributed to the variation in the frequency of the tumours of the intestinal histological type, the incidence of those classified as diffuse seems to have remained stable or even increased over time (Wu et al., 2009) . Similarly, the decline has been more pronounced for tumours located in the lower third of the stomach, whereas the frequency of tumours in the cardia has been increasing, depicting a pattern of change that resembles more closely that observed for oesophageal adenocarcinoma (Botterweck et al., 2000) . Thus, it remains the sixth most common cancer and the third leading cause of cancer-related deaths; the worldwide estimates for incidence and mortality rates in 2008 were 14.6 of 100 000 and 10.9 of 100 000 inhabitants, respectively, with a wide variation across geographical areas (Ferlay et al., 2010) .
The decrease in gastric cancer rates was primarily attributed to a set of factors related to the improvement of the populations' living conditions, namely the increase in the consumption of fruits and vegetables and the decrease in salt intake (Howson et al., 1986) . The discovery of Helicobacter pylori (Marshall and Warren, 1984) , and its classification as a human carcinogen within 10 years (IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1994) , brought a new paradigm to interpret gastric carcinogenesis and temporal/ geographical variation in gastric cancer frequency. H. pylori infection affects more than half of the world adult population, and approximately two-thirds of all gastric cancer cases occurring worldwide are attributed to it (Parkin, 2006) .
Outcomes for epidemiological research on gastric cancer aetiology
Over 95% of gastric malignancies are adenocarcinomas, among which different conditions may be defined according to the site of tumour origin and the histological features of the lesion.
In epidemiological studies, gastric adenocarcinomas are frequently classified according to topography into cardia and noncardia. Tumours described as cardia comprise a mixture of neoplasms arising from the lower oesophagus and the gastric cardia, to a great or lesser extent depending on the frequency of oesophageal and gastric adenocarcinomas in the populations under study (Cavaleiro-Pinto et al., 2011) . The diversity of criteria used to classify the tumours as 'cardia' cancer accounts for some of the heterogeneous results observed across studies reporting cancer trends by subsite (Ekstrom et al., 1999; Corley and Kubo, 2004) or evaluating the determinants of gastric cancers with specific topographies (Lunet et al., 2007; Ladeiras-Lopes et al., 2008; Cavaleiro-Pinto et al., 2011) .
The Laurén's classification system (Laurén, 1965) has been widely used in epidemiological research, subdividing tumours into two main histological types -diffuse and intestinal. Still, the histological classification of an individual gastric adenocarcinoma is sometimes complex because a tumour often presents characteristics of both intestinal and diffuse tissue types. Nevertheless, most gastric cancers belong to the intestinal type which is more common in males, Blacks and older individuals, whereas the diffuse type has a similar incidence in both sexes and is more frequent in younger individuals (Correa et al., 1973) . There is a wide geographical variation in the frequency of intestinal type tumours, whereas the occurrence of diffuse adenocarcinomas is more uniform across regions (Laurén and Nevalainen, 1993) . In addition, the decrease in cancer incidence among migrants from high-risk to low-risk areas has been observed predominantly for tumours of the intestinal type (Correa et al., 1973) . These findings were taken as evidence of a relatively greater impact of environmental factors in the aetiology of intestinal-type carcinomas, whereas the diffuse type was considered more dependent on the individuals' genetic profiles (Tahara, 2004 ).
The association between H. pylori infection and gastric cancer
Ecological studies were the first to quantify the association between infection and cancer (IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1994). The EUROGAST Study Group evaluated 17 populations from 13 countries, chosen to reflect the global range of gastric cancer incidence. Approximately a six-fold increased risk of gastric cancer was found in populations with 100% of H. pylori infection compared with populations that have no infection (The EURO-GAST Study Group, 1993) .
In 1994, a combined analysis of the three pioneer prospective studies, with a follow-up of at least 15 years, showed a nine-fold higher risk among infected patients (Forman et al., 1994) ; the International Agency for Research on Cancer classified H. pylori as a class I definite carcinogen in the same year (IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1994) . According to this report, there was sufficient evidence from research conducted on humans, largely based on epidemiological studies. The association between infection with H. pylori and gastric cancer was stronger in younger patients and for cancers at sites other than the cardia, and similar for the intestinal and diffuse histological types.
This was the first time that a bacterium was recognized as a carcinogen and such strong conclusions were considered premature by some researchers. No experimental studies had been conducted on humans and the results from observational research were heterogeneous, especially those from case-control studies and across regions with different gastric cancer risk (Nyren, 1998) .
At present, research is being focused on an in-depth understanding of the role of infection in the causal mechanisms leading to cancer, and the implications of this knowledge for prevention and control.
A model of causation applied to the association between H. pylori infection and gastric cancer Scope of the model Cancer is currently interpreted as a multifactorial complex disease. According to the causality model proposed by Rothman (1995) , individual risk factors alone cannot be ascribed as causes, and only a set of risk factors, or component causes, may be sufficient for the outcome to occur. Removing any of these components will prevent the outcome. However, for a single disease multiple causal mechanisms leading to its occurrence may coexist, corresponding to different sufficient causes composed of different sets of component causes. Again, to prevent disease, it is not necessary to identify all these components; removing a component that appears in every sufficient cause, therefore defined as a necessary component cause, may be enough. In model 'a', H. pylori is found in all sufficient causes (I, II and III), being defined as a necessary cause for gastric cancer, which, under this model, would be completely preventable by removing infection. In contrast, in model 'b' none of the factors is recognized as a necessary causal component, although each causal mechanism will suffice for the production of gastric cancer. Under this model, removing infection would only lead to the blocking of sufficient cause IV.
To complete this reasoning a temporal dimension needs to be included in the model, as different factors may exert their effects in different phases of the mechanism or some of them may act to produce other mechanisms that ultimately lead to disease.
Induction period
The contribution of a given factor to disease occurrence as well as its interaction with other factors may vary over time due to changes in the prevalence of that causal component and how each of them groups with the remainder to form the various causal mechanisms. The period of time from causal action until disease initiation is Helicobacter pylori infection and gastric cancer Peleteiro et al. 119 defined as the induction period, which depends on the time that each causal component takes to group with others within the same sufficient cause. The early action of some factors may shorten the induction time of others.
In carcinogenesis, the terms initiator and promoter are used to identify component causes that act early and late in the causal mechanism, respectively. This is compatible with the intermediate steps (corresponding to intermediate outcomes) in a causal mechanism and we may postulate the action of the potential causal factors in specific stages of carcinogenesis. Under such an hypothesis, the presence of a sufficient cause for an early outcome is also necessary for other sufficient causes to exert their actions in later outcomes.
The production of empirical evidence to support such a causal model requires the identification of different steps in carcinogenesis, corresponding to intermediate outcomes that precede cancer. A model for the progression of the gastric cancers of the intestinal type has been proposed by Correa et al. (1975) , according to which precancerous lesions occur in sequential steps: atrophy, intestinal metaplasia and dysplasia (Fig. 1) . This model allowed the identification of intermediate stages in the causal mechanism leading to cancer and has provided a framework for understanding the role of different risk factors in different steps of gastric carcinogenesis (Correa, 1992) . Correa's model for gastric carcinogenesis was initially proposed for tumours of the intestinal type (Correa et al., 1975; Correa, 1992) , based on the hypothesis of a greater impact of environmental factors as gastric cancer determinants. However, recent epidemiological studies suggest that the two main gastric cancer types are similarly associated with infection (IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1994; Huang et al., 1998) and lifestyle exposures (Lunet et al., 2007; Peleteiro et al., 2011a) . Furthermore, the intestinal differentiation is not exclusive to the Laurén's intestinal type, and a high proportion of diffuse cancers may also present differentiation markers such as the MUC2 mucin (Pinto- de-Sousa et al., 2002) . The cascade of events that leads to intestinal differentiation is initiated by cdx1 and/or cdx2 (caudal-type homeobox) genes (Guo et al., 2004) , and may result in the development of both intestinal and diffuse gastric carcinoma (Almeida et al., 2003) . CDX2 expression may be seen as an early marker of intestinal differentiation, occurring in the gastric carcinogenesis pathway even earlier than chronic atrophic gastritis or intestinal metaplasia (Eda et al., 2002) . Epidemiological research relying on these tools to define the outcomes is still scarce, but may be important to understand the aetiological heterogeneity of gastric cancer, by providing additional early endpoints in the pathway towards gastric cancer, as well as allowing the definition of subtypes of gastric cancer that are aetiologically more homogeneous.
Empirical evidence supporting the role of H. pylori infection in the causal mechanisms leading to gastric cancer
The above described models provide a conceptual framework to interpret and present systematically the evidence that supports the causal nature of the association between H. pylori infection and gastric cancer.
The meta-analyses that quantified this association (Forman et al., 1994; Huang et al., 1998; Danesh, 1999; Eslick et al., 1999; Helicobacter and Cancer Collaborative Group, 2001; Xue et al., 2001; Cavaleiro-Pinto et al., 2011) yielded summary RR estimates of approximately 2. The magnitude of the association, however, varies according to the methodologies adopted by the original studies and with the characteristics of the tumour samples (Fig. 2) .
In general, the association was stronger when assessed by prospective investigations, and when the lag between the assessment of H. pylori infection status and the diagnosis of gastric cancer was longer. H. pylori clearance tends to occur with the progression to cancer, and infection may not always be present when cancer is diagnosed, which contributes to underestimation of the association between infection and cancer in studies with retrospective case-control designs (Kokkola et al., 2003; Gao et al., 2009; Peleteiro et al., 2010b) . Prospective studies provide a I  II  III H. pylori H. pylori
Possible causal mechanisms for gastric cancer, according to the causality model proposed by Rothman (Rothman, 1995 more accurate assessment of infection and more valid estimates for the risk of gastric cancer among the infected.
When the analyses were restricted to early gastric cancer cases, the RR estimates were also higher, mainly because of the fact that this cancer type is considered as an early stage in the development of gastric cancer, closer to the precancerous lesions, and therefore less prone to differential misclassification of infection status. This is also in accordance with the stronger associations observed between H. pylori and precancerous lesions than with gastric cancer, as infection increases the risk of chronic atrophic gastritis by a factor of approximately 5 (Weck and Brenner, 2008; Adamu et al., 2010) .
Considering the virulence of the infecting strains as a marker of the exposure dose, we observe that, among H. pylori-infected populations, infection with cytotoxin associated-gene A (CagA)-positive strains further increases the risk of gastric cancer (Huang et al., 2003; Cavaleiro-Pinto et al., 2011) . When more sensitive methods, based on the detection of antibodies against CagA, are used to determine infection status, the proportion of H. pyloriinfected cases approaches 100% (Ekstrom et al., 2001; Brenner et al., 2004; Peleteiro et al., 2010b) . Infection with CagA-positive strains may represent a necessary component cause in the different mechanisms leading to gastric cancer, requiring a smaller number of other component causes than mechanisms including infection with H. pylori strains with lower virulence.
Until recently, it was widely accepted that the association between H. pylori infection and gastric cancer was Forest plot depicting the results from meta-analyses on the association between H. pylori infection and gastric cancer, according to different methodological and tumour characteristics. Data sources: Forman et al., 1994; Huang et al., 1998; Danesh, 1999; Eslick et al., 1999; Helicobacter and Cancer Collaborative Group, 2001; Xue et al., 2001; Huang et al., 2003; Cavaleiro-Pinto et al., 2011 . CI, confidence interval; RR, relative risk.
Helicobacter pylori infection and gastric cancer Peleteiro et al. 121 restricted to noncardia cancer, which was taken as evidence of different aetiologies according to topography. However, in high-risk settings the magnitude of the association is similar for both cardia and noncardia cancers (Cavaleiro-Pinto et al., 2011) , supporting the hypothesis that two aetiologically distinct types of cardia cancer could coexist: one similar to the noncardia cancer and highly associated with H. pylori infection, and the other more similar to oesophageal cancer and not related to infection (Hansen et al., 2007; Derakhshan et al., 2008; Bornschein et al., 2010; Peleteiro et al., 2011b) . Therefore, H. pylori infection may be present in causal mechanisms leading to both cardia and noncardia cancers.
Several studies assessed the impact of H. pylori eradication on the risk of gastric cancer. Both randomized and nonrandomized studies provided evidence that supports the potential for prevention of stomach cancer through eradication of the infection (Fuccio et al., 2007 (Fuccio et al., , 2009 Ito et al., 2009 ). However, one of the trials (Wong et al., 2004) analysed separately individuals with and without precancerous lesions, and eradication of H. pylori infection was significantly associated with a decreased risk of developing gastric cancer only among the latter. In contrast, in a trial conducted in Colombia, with all patients presenting gastric precancerous lesions at the baseline evaluation, there was no association between eradication and cancer (Correa et al., 2000; Mera et al., 2005) . This supports the hypothesis that the effects of infection are exerted at the early stages of gastric carcinogenesis. Two recent meta-analyses estimated the impact of H. pylori eradication on the incidence of gastric precancerous lesions, showing a significant reduction in the risk of chronic atrophic gastritis but not of intestinal metaplasia (Rokkas et al., 2007; Wang et al., 2011) . Furthermore, intestinal metaplasia regression was shown to be less frequent in individuals previously infected with high-virulence strains (Barros et al., 2010) . Taken together, these results support the hypothesis that H. pylori eradication must occur before a point of no return, or that cannot be easily reverted, to be effective for cancer prevention.
Despite previous observations suggesting H. pylori infection as a necessary cause for gastric cancer, only a small proportion of infected individuals will reach this endpoint (Uemura et al., 2001; Hsu et al., 2007) , and several other potential causal components have to be considered as part of the causal mechanisms (Fig. 3) .
Furthermore, a direct correlation between H. pylori prevalence and gastric cancer rates is not always observed at an ecological level. In fact, some countries present a low gastric cancer incidence despite the high frequency of infection, the so-called African enigma (Holcombe, 1992) . In these settings the cancer precursor lesions, especially intestinal metaplasia, are also less frequent than expected given the high prevalence of infection (Kidd et al., 1999) . This supports the hypothesis of H. pylori acting at earlier steps of carcinogenesis and that other genetic and/or environmental exposures are needed for the progression towards cancer. Differences in the host response to infection (Mitchell et al., 2002) , the individuals' genetic profiles (Thye et al., 2003) , exposure to environmental hazards and lifestyles (Lunet and Barros, 2003; Peleteiro et al., 2008) , virulence of the H. pylori strains responsible for infection (Louw et al., 2001) or combined bacterial/host genotypic features have been proposed as modulators of the progression towards cancer.
The other component causes
The role of environmental factors in gastric carcinogenesis has been studied and mechanisms by which they can lead to cancer have been proposed (Correa, 1992) . Although salt, fruit and vegetable consumption were the first to be associated with gastric cancer (Howson et al., 1986) , the evidence currently available shows a lack of consistent results and these exposures may have a weaker effect than initially thought (Lunet et al., 2005; World Cancer Research Fund, American Institute for Cancer Research, 2007) . Evidence is also less robust for other lifestyles, such as meat intake (World Cancer Research Fund, American Institute for Cancer Research, 2007) . On the contrary, the association with smoking, not previously accounted for, is now well established (Ladeiras-Lopes et al., 2008) .
The individuals' genetic profiles were not included in the first versions of the model proposed by Correa et al. (1975) and Correa (1992) but, along with the advent of new technologies and their use in epidemiological research, several studies addressing the association between genetic polymorphisms and gastric cancer have been conducted. In the aetiological model of gastric cancer, individual genetic susceptibility may be critical in a variety of processes relevant to gastric carcinogenesis (Gonzalez et al., 2002) . The most widely studied polymorphisms, and for which more promising results have been achieved, are those related to proinflammatory cytokines, within interleukin-1 and tumour necrosis factor a gene clusters (Camargo et al., 2006; Kamangar et al., 2006; Gorouhi et al., 2008; Vincenzi et al., 2008; Loh et al., 2009; Peleteiro et al., 2010a) .
Conclusion
In conclusion, we have been witnessing the gradual acceptance of H. pylori infection as the most important environmental factor contributing to the burden of gastric cancer. The accumulated evidence suggests causal mechanisms in which H. pylori infection plays the role of necessary component cause. The confirmation of this hypothesis would be a major achievement of cancer epidemiology, as it may translate into the possibility of preventing gastric cancer by acting on a single modifiable exposure. However, the understanding of the usefulness of the available tools for eradication of infection, as well as future vaccines or other primary prevention strategies, also depends on our knowledge on the role of infection in the different causal mechanisms at a finer level. The fact that infection may act predominantly as an initiator or the existence of points of no return in the gastric carcinogenesis pathway may restrict the time window for cancer prevention actions based on the control of infection. These strategies may be complemented by the control of Forest plot depicting the results from meta-analyses on the association between lifestyle and genetic factors and gastric cancer. Data sources: Tredaniel et al., 1997; Riboli and Norat, 2003; Lunet et al., 2005; Camargo et al., 2006; Kamangar et al., 2006; Larsson et al., 2006; Lunet et al., 2007; World Cancer Research Fund, American Institute for Cancer Research, 2007; Gorouhi et al., 2008; Ladeiras-Lopes et al., 2008; Vincenzi et al., 2008; Loh et al., 2009 . CI, confidence interval; IL-1, interleukin 1; RR, relative risk; TNF-a, tumour necrosis factor.
Helicobacter pylori infection and gastric cancer Peleteiro et al. 123 other component causes, which require the understanding of the step-specific causal mechanisms leading to gastric cancer.
